SAB Biotherapeutics, Inc.
Key Metrics
Market Snapshot
About
SAB Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing human polyclonal antibody therapeutics using its proprietary DiversitAb platform. The company genetically engineers cattle to produce fully human antibodies that can target a wide range of infectious diseases, cancer, and autoimmune disorders. SAB Biotherapeutics has developed therapeutic candidates for diseases including COVID-19, influenza, and other emerging infectious threats.